Celcuity awaits FDA review for second factory to launch cancer drug
Celcuity has provided further details on why the commercial rollout of its recently approved cancer drug is slower than investors initially anticipated. The drugmaker said it is waiting for the FDA to review a second ...
August 17, 2026 09:19 AM EDT PharmaManufacturing Celcuity awaits FDA review for second factory to launch cancer drug Anna Brown News Reporter Celcuity has provided further details on why the commercial rollout of its recently approved cancer drug is slower than investors initially anticipated. The drugmaker said … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that